2005, Number 3
Bol Med Hosp Infant Mex 2005; 62 (3)
Non oncologic causes of Kinsbourne syndrome.
Barragán-Pérez E, Velarde-Espinosa S, Garza-Morales S, Hernández-Aguilar J
PDF size: 118.35 Kb.
In 1962 Kinsbourne describes a triad characterized by opsoclonus, myoclonus and ataxia. The incidence is rare; it occurs predominantly in pediatric population. It may express different etiologies; the most frequently cause associated is with paraneoplasia (50% with neuroblastoma). The great variety of diagnosis proposed for the Kinsbourne syndrome (KS) implies a great number of treatments too. Besides KS is rarely seen,the dramatic presentation, sudden appear, characterized triad and torpid evolution that can be in relationshipwith a paraneoplasia makes the syndrome a entity of great interest for the medical doctors, making of great importance known the different etiologies of each community for establish standardized protocols for the clinical study and follow adequate for these patients. With this revision, we suspect to identify the different etiologies in the KS in the population attended in the Hospital Infantil de Mexico Federico Gomez (HIMFG).
describe and analyze the different causes of KS attended in the HIMFG between 1990-2004.
Material and methods.
With a retrospective study,we include patients of both sexes, ‹ 16 years,seen between 1990 and 2004. We study the frequency of patients seen in that period, the most frequent etiologies and the evolution of these patients.
Of 26 patients, the most frequent age of presentation was 21 months of age. The time between the first symptoms and the diagnosis was approx. 3.8 months. The initial symptom in 88.5% was ataxia. The most frequent etiologies related were infections, craneoencephalic trauma and inflammatory process. In 27% of the patients there were no antecedents. Only one of the patients was associated with neuroblastoma.
The infection was the most frequent cause in our series that results implies the necessityto make strategies in the search of these patients.
Verma A. Opsoclonus-myoclonus syndrome following Epstein-Barr virus infection. Neurology. 2002; 58: 7.
Kaplan M. Sur une variete d´ataxie cerebelleuse acquiese de l´enfance avec tremblement oculaire. Arch Fr Pediatr. 1959; 16: 1124-9.
Kinsbourne M. Myoclonic encephalopathy in infants. J Neurol Neurosurg Psychiatry. 1962; 25: 271-9.
Dyken P, Kolar O. Dancing eyes, dancing feet: infantile polymyoclonia. Brain. 1968; 91: 305-20.
Swaiman KF, Ashwal S. Movement disorders and disorders of the basal ganglia. Pediatric neurology. Principles and practice. Third ed. St. Louis, Missouri: Editorial 1999. Vol. II. p. 818-9.
Rodríguez-Barrionuevo AC. Síndrome de Kinsbourne: revisión de nuestra casuística. Rev Neurol. 1998; 26: 956-9.
Inuzuka T. Paraneoplastic opsoclonus myoclonus syndrome (POMS). Ryoikibetsu Shokogun Shirizu. 2000; 31: 62-4.
Mitchell W. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae. Pediatrics. 2002; 109: 1.
Parisi MT. Optimized diagnostic strategy for neuroblastoma in opsoclonus myoclonus. J Nucl Med. 1993; 34: 1922-6.
Rosenfeld M. Clinical spectrum and pathogenesis of paraneoplastic disorders of the central nervous system. Hematol Oncol Clin North Am. 2001; 15: 6.
Kay CL. Paraneoplastic opsoclonus-myoclonus in Hodgkin’s disease. J Neurol Neurosurg Psychiatry. 1993; 56: 831-2.
Wilfong AA. Opsoclonus-myoclonus with Beckwith-Wiedemann syndrome and hepatoblastoma. Pediatr Neurol. 1992; 8: 77-9.
Tabarki B. Spontaneous recovery of opsoclonus-myoclonus syndrome caused by enterovirus infection. J Neurol Neurosurg Psychiatry. 1998; 64: 406-7.
García-Morales I. Opsoclonus-myoclonus in a patient with AIDS: a good response to treatment with IV immunoglobulin. Rev Neurol. 1999; 29: 1346-8.
Ichiba N. Mumps-induced opsoclonus-myoclonus and ataxia. Pediatr Neurol. 1988; 4: 224-7.
Ramos S. Síndrome de opsoclono-mioclono. ¿Hasta cuándo seguir investigando? Rev Neurol. 2002; 35: 322-5.
Pranzatelli MR. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol. 1996; 19: 1-47.
Pranzatelli MR. Antibodies to ACTH in opsoclonus-myoclonus. Neuropediatr. 1993; 24: 131-3.
Noetzel MJ. Anti-neurofilament protein antibodies in opsoclonus-myoclonus. J Neuroimmunol. 1987; 15: 137-45.
Hersh B. Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody. Neurology. 1994; 44: 1754-5.
Andrade-Machado R. Síndrome opsoclono-mioclono- atáxico. Rev Neurol. 2001; 32: 440-3.
Fejerman N, Fernández-Alvarez ZE. Neurología pediátrica. Buenos Aires: El Ateneo; 1989.